NCT06576440View on ClinicalTrials.gov

Effects of Ghrelin Administration on Motivation

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Major Depressive Disorder
Interventions
DRUG

Ghrelin

Participants in this arm will receive a subcutaneous injection of acyl-ghrelin as the active condition.

DRUG

Saline

Participants in this arm will receive a subcutaneous injection of saline as placebo control condition.

Trial Locations (1)

72076

Department of Psychiatry & Psychotherapy, University of Tübingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER